US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 4.5900
  • -0.0700-1.50%
Close Dec 26 16:00 ET
3.32MMarket Cap-0.60P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
40.23%1.26M
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
77.22%469.78K
Operating revenue
40.23%1.26M
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
77.22%469.78K
Cost of revenue
-12.42%771.23K
27.97%3.5M
10.30%817K
4.96%883.14K
170.53%916.06K
8.48%880.62K
400.56%2.73M
179.46%740.69K
560.93%841.41K
120.55%338.62K
Gross profit
2,222.82%493.41K
-21.53%1.1M
-70.32%466.07K
50.36%289.46K
147.13%324.14K
104.33%21.24K
158.13%1.4M
528.87%1.57M
5.61%192.51K
17.58%131.16K
Operating expense
-15.04%2.25M
-5.59%9.24M
18.62%2.48M
-10.94%2.09M
-14.22%2.03M
-11.46%2.65M
-31.76%9.78M
-36.71%2.09M
-37.08%2.34M
-46.53%2.37M
Selling and administrative expenses
9.49%1.42M
-10.21%5.25M
-13.87%1.21M
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-20.25%1.46M
-General and administrative expense
9.49%1.42M
-10.21%5.25M
-13.87%1.21M
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-20.25%1.46M
Research and development costs
-40.32%771.18K
0.88%3.77M
93.41%1.21M
-25.22%656.76K
-28.37%609.79K
-6.28%1.29M
-48.75%3.73M
-58.44%623.74K
-49.91%878.3K
-66.44%851.36K
Depreciation amortization depletion
-0.46%54.58K
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-1.50%49.05K
-Depreciation and amortization
-0.46%54.58K
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-1.50%49.05K
Operating profit
33.16%-1.75M
2.92%-8.13M
-289.14%-2.01M
16.43%-1.8M
23.69%-1.7M
24.57%-2.62M
39.25%-8.38M
83.06%-516.26K
39.28%-2.15M
48.19%-2.23M
Net non-operating interest income expense
-58.03%57.09K
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
340.68%115.8K
Non-operating interest income
-58.03%57.09K
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
340.68%115.8K
Other net income (expense)
139.85%19.31K
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
99.02%-48.18K
100.64%31.11K
-108.28%-2.73K
573.00%20.24K
Gain on sale of security
139.85%19.31K
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
96.64%-48.18K
102.25%31.11K
-108.28%-2.73K
573.00%20.24K
Income before tax
33.86%-1.68M
3.35%-7.67M
-473.57%-1.93M
13.70%-1.72M
29.55%-1.48M
27.59%-2.54M
57.34%-7.93M
95.72%-336.59K
42.56%-2M
51.01%-2.1M
Income tax
0
-45.80%7.1K
294.44%7.1K
0
0
0
13.1K
1.8K
1.5K
3K
Net income
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
Net income continuous Operations
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
Minority interest income
Net income attributable to the parent company
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
Basic earnings per share
82.22%-54.2
68.92%-20.2
-167.86%-3.8
70.00%-3.6
79.12%-3.8
-275.37%-304.8
90.20%-65
102.15%5.6
90.23%-12
88.23%-18.2
Diluted earnings per share
82.22%-54.2
68.92%-20.2
-167.86%-3.8
70.00%-3.6
79.12%-3.8
-275.37%-304.8
90.20%-65
102.15%5.6
90.23%-12
88.23%-18.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 40.23%1.26M11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M77.22%469.78K
Operating revenue 40.23%1.26M11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M77.22%469.78K
Cost of revenue -12.42%771.23K27.97%3.5M10.30%817K4.96%883.14K170.53%916.06K8.48%880.62K400.56%2.73M179.46%740.69K560.93%841.41K120.55%338.62K
Gross profit 2,222.82%493.41K-21.53%1.1M-70.32%466.07K50.36%289.46K147.13%324.14K104.33%21.24K158.13%1.4M528.87%1.57M5.61%192.51K17.58%131.16K
Operating expense -15.04%2.25M-5.59%9.24M18.62%2.48M-10.94%2.09M-14.22%2.03M-11.46%2.65M-31.76%9.78M-36.71%2.09M-37.08%2.34M-46.53%2.37M
Selling and administrative expenses 9.49%1.42M-10.21%5.25M-13.87%1.21M-2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M-20.25%1.46M
-General and administrative expense 9.49%1.42M-10.21%5.25M-13.87%1.21M-2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M-20.25%1.46M
Research and development costs -40.32%771.18K0.88%3.77M93.41%1.21M-25.22%656.76K-28.37%609.79K-6.28%1.29M-48.75%3.73M-58.44%623.74K-49.91%878.3K-66.44%851.36K
Depreciation amortization depletion -0.46%54.58K8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K-1.50%49.05K
-Depreciation and amortization -0.46%54.58K8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K-1.50%49.05K
Operating profit 33.16%-1.75M2.92%-8.13M-289.14%-2.01M16.43%-1.8M23.69%-1.7M24.57%-2.62M39.25%-8.38M83.06%-516.26K39.28%-2.15M48.19%-2.23M
Net non-operating interest income expense -58.03%57.09K7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K340.68%115.8K
Non-operating interest income -58.03%57.09K7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K340.68%115.8K
Other net income (expense) 139.85%19.31K-28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K49.94%-48.46K99.02%-48.18K100.64%31.11K-108.28%-2.73K573.00%20.24K
Gain on sale of security 139.85%19.31K-28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K49.94%-48.46K96.64%-48.18K102.25%31.11K-108.28%-2.73K573.00%20.24K
Income before tax 33.86%-1.68M3.35%-7.67M-473.57%-1.93M13.70%-1.72M29.55%-1.48M27.59%-2.54M57.34%-7.93M95.72%-336.59K42.56%-2M51.01%-2.1M
Income tax 0-45.80%7.1K294.44%7.1K00013.1K1.8K1.5K3K
Net income 33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M
Net income continuous Operations 33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M
Minority interest income
Net income attributable to the parent company 33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M
Basic earnings per share 82.22%-54.268.92%-20.2-167.86%-3.870.00%-3.679.12%-3.8-275.37%-304.890.20%-65102.15%5.690.23%-1288.23%-18.2
Diluted earnings per share 82.22%-54.268.92%-20.2-167.86%-3.870.00%-3.679.12%-3.8-275.37%-304.890.20%-65102.15%5.690.23%-1288.23%-18.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
SilverCrest Metals
SILV
+2.40%
Cars.com
CARS
+2.25%
Lantheus
LNTH
+2.14%
Collegium Pharmaceutical
COLL
+1.48%
Hutchmed (China)
HCM
+1.19%

Unlock the Full List